ArticleThe Lancet regional health. Western Pacific2024

Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data.

Brendon L Neuen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.